Search the full ICD-10 catalog by:
Why ICD-10 codes are important
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
ICD-10 code R73 for Elevated blood glucose level is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10-CM Code for Encounter for preprocedural laboratory examination Z01. 812.
Table 1: HCPCS/CPT Codes and DescriptorsHCPCS/CPT CodesCode Descriptors82947Glucose; quantitative, blood (except reagent strip)82950Glucose; post glucose dose (includes glucose)82951Glucose Tolerance Test (GTT); three specimens (includes glucose)83036Hemoglobin A1C
You would assign ICD-10 code Z13. 1, Encounter for screening for diabetes mellitus. This code can be found under “Screening” in the Alphabetical Index of the ICD-10 book.
Encounter for screening for other metabolic disorders Z13. 228 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z13. 228 became effective on October 1, 2021.
List of Top Laboratory Testing: CPT Codes 80000-89999CPTDESCRIPTIONAverage Charge8557685576 PLATELET FUNCTION SCREEN$302.008500285002 BLEEDING TIME$446.008537985379 D DIMER (QUANT)$129.00DNA TEST COLLECTION/PREP FEE$159.006 more rows
1.
09: Other abnormal glucose.
ICD-Code E11* is a non-billable ICD-10 code used for healthcare diagnosis reimbursement of Type 2 Diabetes Mellitus. Its corresponding ICD-9 code is 250. Code I10 is the diagnosis code used for Type 2 Diabetes Mellitus.
9.
HbA1c is widely accepted as medically necessary for the management and control of patients with diabetes. It is also valuable to assess hyperglycemia, a history of hyperglycemia or dangerous hypoglycemia.
ICD-10 code E10. 9 for Type 1 diabetes mellitus without complications is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
R73.09 is a billable diagnosis code used to specify a medical diagnosis of other abnormal glucose. The code R73.09 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
0.5 mL serum or 0.5 mL plasma ( Note: This volume does not allow for repeat testing.)
Gel-barrier tube (1) or gray-top (sodium fluoride/potassium oxalate plasma) tube (1)
Collect specimen two hours from the beginning of meal. Separate serum or plasma from cells within 45 minutes of venipuncture. Gray-top tubes only, may be submitted without centrifugation. Label tube with patient's name and collection time.
Adequate meal or 75-gram glucose load two hours before two-hour postprandial glucose, as specified by the patient's physician. Patient is allowed usual meal (breakfast or lunch). Patient must complete meal within 15 to 20 minutes.
Stressed patients (surgery, infection, corticosteroids) should not have GTT; specimens not labeled with collection time